Ovarian Cancer Patient Questionnaire on Genetic Testing

Completed

• Conditions: Ovarian Cancer
• Interventions: Behavioral: Questionnaire

• Registration Number: NCT00486707
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.

Detailed Description

All eligible patients being seen in the Gynecology Center at the M.D. Anderson Cancer Center and at Gynecologic Oncology of Houston for follow-up or a new diagnosis of ovarian cancer will be asked to participate in this study by completing a questionnaire.

This study will end when 400 completed questionnaires have been collected. We estimate that 40-60 ovarian cancer patients are seen in the Gynecology Center at the M.D. Anderson Cancer Center each week and that 20- 40 ovarian cancer patients are seen at Gynecologic Oncology of Houston each week. The completion of 400 questionnaires will provide adequate data to address our question in an expeditious time frame. The initial phase of this study is exploratory and does not involve a comparison group.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2007-06
• Study First Submitted: 2007-06-13
• Study First Submitted QC: 2007-06-13
• Study First Posted: 2007-06-15
• Primary Completion: 2008-10
• Study Completion: 2008-10
• Status Verified: 2012-07
• Last Update Submitted: 2012-07-31
• Last Update Posted: 2012-08-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 237

Inclusion Criteria

• Patients must have the diagnosis of ovarian cancer.
• Patients must be at least 18 years of age at the time of enrollment.
• Patients must be able to read and write in the English language.

Read More

Exclusion Criteria

• Patients that are unable to speak or write in the English language. Currently, the investigators' resources in genetic counseling are limited. In the future, they plan to expand the questionnaire and study to include additional languages.
• Patients having previously undergone BRCA genetic testing.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with ovarian cancer	Questionnaire	-

Primary Outcome Measures

Name	Time	Method
Participants' Response to Survey Questions (Yes/No)	15-20 minutes to complete survey

Trial Locations

Locations (1)

U.T.M.D. Anderson Cancer Center; 🇺🇸 Houston, Texas, United States